Information:
Error:
Keywords
Schizophrenia
×
- Clinical Trial (338)
- Eligibility Determination (244)
- Psychiatry (229)
- Drug trial (42)
- Therapeutics (29)
- Vital Signs (28)
- Pregnancy (19)
- Electrocardiogram (ECG) (16)
- Substance Abuse Detection (14)
- Alzheimer Disease (14)
- Memory Disorders (13)
- Adverse event (9)
- Psychiatric Status Rating Scales (8)
- Antipsychotic Agents (7)
- Trial screening (6)
- Physical Examination (5)
- Concomitant Medication (5)
- End of Study (5)
- Clinical Protocols (5)
- Comment (4)
- Pharmacogenetics (3)
- Mental Disorders (3)
- Urinalysis (3)
- Schizophrenia and Disorders with Psychotic Features (3)
- Follow-Up Studies (3)
- Laboratories (3)
- Pharmacokinetics (2)
- Pregnancy Tests (2)
- Quality of Life (2)
- Drugs, Investigational (2)
- Clinical Chemistry Tests (2)
- Positron-Emission Tomography (2)
- Transcriptome (2)
- Demography (2)
- Diabetes Mellitus (2)
- Diabetes Mellitus, Type 2 (2)
- Alcohol Drinking (2)
- Hematology (2)
- Magnetic Resonance Imaging (2)
- Recurrence (1)
- Respiratory Function Tests (1)
- Serology (1)
- Cognitive Therapy (1)
- Smoking Cessation (1)
- Tobacco Use (1)
- Pragmatic Clinical Trial (1)
- Baseline (1)
- Common Data Elements (CDE) (1)
- Dental Hygiene (1)
- Released Standard (1)
- Diagnostic Imaging (1)
- Disease (1)
- HIV (1)
- Hospitalization (1)
- Liver (1)
- Medical History Taking (1)
Table of contents
Selected data models
You must log in to select data models for download or further analysis.
362 Search results.
Itemgroups:
Inclusion Criteria, Exclusion Criteria
Itemgroups:
Inclusion Criteria, Exclusion Criteria
Itemgroups:
Inclusion Criteria, Exclusion Criteria
Itemgroups:
Inclusion Criteria, Exclusion Criteria
Itemgroups:
Administrative documentation, Allen test, Vital signs, Pulmonary function tests, 12 lead ECG, Holter Electrocardiography, Positron-Emission Tomography, Pre-dose, Pharmacokinetic aspects - Blood, Randomization, Numbers, Therapeutic procedure, Confirmation, Experimental drug, Positron-Emission Tomography, Post-dose, Physical Examination, Post-dose, Vital signs, Post-dose, Laboratory Procedures, Post-dose, Hematology finding, Laboratory Procedures, Post-dose, Chemistry, Clinical, Urinalysis, Post-dose, Laboratory Procedures, Post-dose, Renal function
Itemgroups:
Administrative documentation, Investigator Signature
Itemgroups:
Administrative documentation, Clinical Investigators, Comment
Itemgroups:
Administrative documentation, Clinical Trials, Conclusion
Itemgroups:
Administrative documentation, Pregnancy, Information
Itemgroups:
Administrative documentation, Serious Adverse Event, Serious Adverse Event, Seriousness of Adverse Event, Serious Adverse Event, Demography, Serious Adverse Event, Relationships, Experimental drug, Serious Adverse Event, Etiology aspects, Serious Adverse Event, Disease, Serious Adverse Event, Risk factors, Serious Adverse Event, Concomitant Agent, Serious Adverse Event, Experimental drug, Details, Serious Adverse Event, Diagnostic Procedure, Serious Adverse Event, Comment, Serious Adverse Event, Investigator Signature
Itemgroups:
Administrative documentation, Non-serious Adverse Event
Itemgroups:
Administrative documentation, Concomitant Agent